The Role Of Psychobiotics In Various Neurological Diseases
Özet
Psychobiotics, defined as beneficial microorganisms that enhance neurological and mental well-being when administered at appropriate doses, have emerged as a significant therapeutic frontier for managing neurological disorders. These microbes influence the central nervous system through several pathways, including modulating the gut microbiota, synthesizing neuroactive metabolites and neurotransmitters, regulating immune responses, and preserving the intestinal barrier. Growing research suggests that psychobiotics may help prevent and manage various brain disorders by mitigating neuroinflammation, supporting brain health, and improving neuronal signaling. This chapter examines the mechanisms and properties of psychobiotics, focusing on their roles in neurotransmitter production and therapeutic potential across various neurological conditions.
Referanslar
Wang S, Xu C, Liu H, et al. Connecting the gut microbiota and neurological diseases: the role of bile acids. Molecular Neurobiology. 2023;60:4618–4640. doi:10.1007/s12035-023-03340-9
Matheson JAT, Holsinger RMD. The role of fecal microbiota transplantation in the treatment of neurodegenerative diseases: a review. International Journal of Molecular Sciences. 2023;24:1001. doi:10.3390/ijms24021001
Carabotti M, Scirocco A, Maselli MA, et al. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology. 2015;28:203–209.
Dinan TG, Cryan JF. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. The Journal of Physiology. 2017;595:489–503. doi:10.1113/JP273106
Foster JA, Neufeld KAM. Gut-brain axis: how the microbiome influences anxiety and depres- sion. Trends in Neurosciences. 2013;36:305–312. doi:10.1016/j.tins.2013.01.005
Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences of the United States of America. 2011;108:16050–16055. doi:10.1073/pnas.1102999108
Varesi A, Pierella E, Romeo M, et al. The potential role of gut microbiota in Alzheimer’s disease: from diagnosis to treatment. Nutrients. 2022;14:668. doi:10.3390/nu14030668
Yadav H, Bhardwaj R, Bakshi A, et al. Unveiling the role of gut-brain axis in regulating neu- rological diseases: a comprehensive review. Life Sciences. 2023;330:122022. doi:10.1016/j. lfs.2023.122022
Chen Y, Zhou J, Wang L. Role and mechanism of gut microbiota in human disease. Frontiers in Cellular and Infection Microbiology. 2021;11:625913. doi:10.3389/fcimb.2021.625913
Mangiola F, Nicoletti A, Gasbarrini A, et al. Gut microbiota and aging. European Review for Me- dical and Pharmacological Sciences. 2018;22:7404–7413. doi:10.26355/eurrev_201811_16280
Dahiya D, Nigam PS. Probiotics, prebiotics, synbiotics, and fermented foods as potential bi- otics in nutrition improving health via microbiome-gut-brain axis. Fermentation. 2022;8:303. doi:10.3390/fermentation8070303
Paiva HR, Duarte-Silva E, Alves E, et al. The role of prebiotics in cognition, anxiety, and depres- sion. European Neuropsychopharmacology. 2020;34:1–18. doi:10.1016/j.euroneuro.2020.03.006
Pant A, Maiti TK, Mahajan D, et al. Human gut microbiota and drug metabolism. Microbial Ecology. 2022;84:1–15. doi:10.1007/s00248-022-02081-x
Illiano P, Brambilla R, Parolini C. The mutual interplay of gut microbiota, diet and human dis- ease. The FEBS Journal. 2020;287:833–855. doi:10.1111/febs.15217
McQuade JL, Daniel CR, Helmink BA, et al. Modulating the microbiome to improve therapeutic response in cancer. The Lancet Oncology. 2019;20:e77–e91. doi:10.1016/S1470-2045(18)30952- 5
Rinninella E, Raoul P, Cintoni M, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7:14. doi:10.3390/microorganisms7010014
Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. The New Eng- land Journal of Medicine. 2016;375:2369–2379. doi:10.1056/NEJMra1600266
Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain.
Nature Reviews Microbiology. 2012;10:735–742. doi:10.1038/nrmicro2876
Chen F, Hou K, Chen ZS. Gut microbes regulate the feeding center: a new discovery of gut- brain axis. Signal Transduction and Targeted Therapy. 2022;7:284. doi:10.1038/s41392-022- 01117-5
Naseribafrouei A, Hestad K, Avershina E, et al. Correlation between the human fecal micro- biota and depression. Neurogastroenterology & Motility. 2014;26:1155–1162. doi:10.1111/ nmo.12378
Jiang H, Ling Z, Zhang Y, et al. Altered fecal microbiota composition in patients with ma- jor depressive disorder. Brain, Behavior, and Immunity. 2015;48:186–194. doi:10.1016/j. bbi.2015.03.016
Cattaneo A, Cattane N, Galluzzi S, et al. Association of brain amyloidosis with pro-inflamma- tory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiology of Aging. 2017;49:60–68. doi:10.1016/j.neurobiolaging.2016.08.019
Vogt NM, Kerby RL, Dill-McFarland KA, et al. Gut microbiome alterations in Alzheimer’s dis- ease. Scientific Reports. 2017;7:13537. doi:10.1038/s41598-017-13601-y
Mezzelani A, Landini M, Facchiano F, et al. Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis. Nutritional Neuros- cience. 2015;18:145–161. doi:10.1179/1476830514Y.0000000108
Rogers GB, Keating DJ, Young RL, et al. From gut dysbiosis to altered brain function and men- tal illness: mechanisms and pathways. Molecular Psychiatry. 2016;21:738–748. doi:10.1038/ mp.2016.50
Sarkar A, Lehto SM, Harty S, et al. Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends in Neurosciences. 2016;39:763–781. doi:10.1016/j.tins.2016.09.002
Tremblay A, Lingrand L, Maillard M, et al. The effects of psychobiotics on the microbio- ta-gut-brain axis in early-life stress and neuropsychiatric diseases. Progress in Neuro-Psychop- harmacology and Biological Psychiatry. 2021;105:110142. doi:10.1016/j.pnpbp.2020.110142
Mörkl S, Butler MI, Holl A, et al. Probiotics and the microbiota-gut-brain axis: focus on psychi- atry. Current Nutrition Reports. 2020;9:171–182. doi:10.1007/s13668-020-00313-5
Parte A, Sardà-Carbasse J, Meier-Kolthoff J, et al. List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. International Journal of Systematic and Evolutio- nary Microbiology. 2020;70:5607–5612. doi:10.1099/ijsem.0.004332
Kristensen NB, Bryrup T, Allin KH, et al. Alterations in fecal microbiota composition by pro- biotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Medicine. 2016;8:52. doi:10.1186/s13073-016-0300-5
Singh R, Chang HW, Yan D, et al. Influence of diet on the gut microbiome and implications for human health. Journal of Translational Medicine. 2017;15:73. doi:10.1186/s12967-017-1175-y
McKean J, Naug H, Nikbakht E, et al. Probiotics and subclinical psychological symptoms in healthy participants: a systematic review and meta-analysis. The Journal of Alternative and Complementary Medicine. 2017;23:249–258. doi:10.1089/acm.2016.0023
Grant MC, Baker JS. An overview of the effect of probiotics and exercise on mood and associ- ated health conditions. Critical Reviews in Food Science and Nutrition. 2016;56:23–47. doi:10.1 080/10408398.2013.818932
Ohland CL, Kish L, Bell H, et al. Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psycho- neuroendocrinology. 2013;38:1738–1747. doi:10.1016/j.psyneuen.2013.02.008
Diez-Gutiérrez L, San Vicente L, Barrán LJR, et al. Gamma-aminobutyric acid and probiotics: multiple health benefits and their future in the global functional food and nutraceuticals mar- ket. Journal of Functional Foods. 2020;64:103669. doi:10.1016/j.jff.2019.103669
Strandwitz P, Kim KH, Terekhova D, et al. GABA-modulating bacteria of the human gut micro- biota. Nature Microbiology. 2019;4:396–403. doi:10.1038/s41564-018-0307-3
Akbari E, Asemi Z, Daneshvar Kakhaki R, et al. Effect of probiotic supplementation on cog- nitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and controlled trial. Frontiers in Aging Neuroscience. 2016;8:256. doi:10.3389/fnagi.2016.00256
Xiao J, Katsumata N, Bernier F, et al. Probiotic Bifidobacterium breve in improving cog- nitive functions of older adults with suspected mild cognitive impairment: a randomized, double-blind, placebo-controlled trial. Journal of Alzheimer’s Disease. 2020;77:139–147. doi:10.3233/JAD-200488
Shaaban SY, El Gendy YG, Mehanna NS, et al. The role of probiotics in children with autism spectrum disorder: a prospective, open-label study. Nutritional Neuroscience. 2018;21:676–681. doi:10.1080/1028415X.2017.1347746
Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, dou- ble-blind, placebo-controlled trial. Nutrition. 2016;32:315–320. doi:10.1016/j.nut.2015.09.003
Wallace CJ, Milev RV. The efficacy, safety, and tolerability of probiotics on depression: clinical results from an open-label pilot study. Frontiers in Psychiatry. 2021;12:618279. doi:10.3389/ fpsyt.2021.618279
Yamamura R, Okubo R, Katsumata N, et al. Lipid and energy metabolism of the gut microbiota is associated with the response to probiotic Bifidobacterium breve strain for anxiety and depres- sive symptoms in schizophrenia. Journal of Personalized Medicine. 2021;11:987. doi:10.3390/ jpm11100987
Dickerson FB, Stallings C, Origoni A, et al. Effect of probiotic supplementation on schizo- phrenia symptoms and association with gastrointestinal functioning: a randomized, place- bo-controlled trial. Primary Care Companion for CNS Disorders. 2014;16:PCC.13m01579. doi:10.4088/PCC.13m01579
Cummings JH, Macfarlane GT, Englyst HN. Prebiotic digestion and fermentation. The Ameri- can Journal of Clinical Nutrition. 2001;73:415S–420S. doi:10.1093/ajcn/73.2.415s
Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: The International Sci- entific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology. 2017;14:506–514. doi:10.1038/nrgastro.2017.75
Simpson HL, Campbell BJ. Dietary fibre-microbiota interactions. Alimentary Pharmacology & Therapeutics. 2015;42:158–179. doi:10.1111/apt.13248
Savignac HM, Corona G, Mills H et al (2013) Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochem Int 63:756-764. https://doi.org/10.1016/j.neuint.2013.10.006
Martinowich K, Lu B (2008) Interaction between BDNF and serotonin: role in mood diseases. Neuropsychopharmacology 33:73-83. https://doi.org/10.1038/sj.npp.1301571
Freijy TM, Cribb L, Oliver G et al (2023) Effects of a high-prebiotic diet versus probiotic sup- plements versus synbiotics on adult mental health: The “Gut Feelings” randomised controlled trial. Front Neurosci 16:1097278. https://doi.org/10.3389/fnins.2022.1097278
Chung YC, Jin HM, Cui Y et al (2014) Fermented milk of Lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults. J Funct Foods 10:465-474. https://doi.org/10.1016/j.jff.2014.07.007
van de Wouw M, Walsh AM, Crispie F et al (2020) Distinct actions of the fermented beverage kefir on host behaviour, immunity and microbiome gut-brain modules in the mouse. Microbi- ome 8:3. https://doi.org/10.1186/s40168-019-0746-6
Hwang YH, Park S, Paik JW et al (2019) Efficacy and safety of Lactobacillus plantarum C29-fermented soybean (DW2009) in individuals with mild cognitive impairment: a 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial. Nutrients 11:305. https://doi.org/10.3390/nu11020305
Del Toro-Barbosa M, Hurtado-Romero A, Garcia-Amezquita LE, García-Cayuela T (2020) Psychobiotics: mechanisms of action, evaluation methods and effectiveness in applications with food products. Nutrients 12:3896. https://doi.org/10.3390/nu12123896
Kakee A, Takanaga H, Terasaki T et al (2001) Efflux of a suppressive neurotransmitter, GABA, across the blood-brain barrier. J Neurochem 79:110-118. https://doi.org/10.1046/j.1471- 4159.2001.00540.x
Duranti S, Ruiz L, Lugli GA et al (2020) Bifidobacterium adolescentis as a key member of the human gut microbiota in the production of GABA. Sci Rep 10:14112. https://doi.org/10.1038/ s41598-020-70986-z
Barrett E, Ross RP, O’Toole PW et al (2012) Œ≥-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 113:411-417. https://doi.org/10.1111/ j.1365-2672.2012.05344.x
Foster JA, Neufeld KAM (2013) Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36:305-312. https://doi.org/10.1016/j.tins.2013.01.005
Siragusa S, De Angelis M, Di Cagno R et al (2007) Synthesis of γ-aminobutyric acid by lactic acid bacteria isolated from a variety of Italian cheeses. Appl Environ Microbiol 73:7283-7290. https://doi.org/10.1128/AEM.01064-07
Mazzoli R, Pessione E (2016) The neuro-endocrinological role of microbial glutamate and GABA signaling. Front Microbiol 7:1934. https://doi.org/10.3389/fmicb.2016.01934
Kobayashi K (2001) Role of catecholamine signaling in brain and nervous system functions: new insights from mouse molecular genetic study. J Investig Dermatol Symp Proc 6:115-121. https://doi.org/10.1046/j.0022-202x.2001.00011.x
Sarkodie EK, Zhou S, Baidoo SA, Chu W (2019) Influences of stress hormones on microbial infections. Microb Pathog 131:270-276. https://doi.org/10.1016/j.micpath.2019.04.013
Liu G, Chong HX, Chung FY, et al. (2020) Lactobacillus plantarum DR7 modulated bowel movements and gut microbiota associated with dopamine and serotonin pathways in stressed adults. Int J Mol Sci 21:4608. https://doi.org/10.3390/ijms21134608
Liu X, Jiang L, Li L et al (2020) The role of neurotransmitters in the protection of Caenorhab- ditis elegans for Salmonella infection by Lactobacillus. Front Cell Infect Microbiol 10:554052. https://doi.org/10.3389/fcimb.2020.554052
Fan HX, Sheng S, Li DD et al (2022) Heat-killed Lactobacillus murinus confers neuroprotec- tion against dopamine neuronal loss by targeting NLRP3 inflammasome. Bioeng Transl Med 8:e10455. https://doi.org/10.1002/btm2.10455
Gao J, Xu K, Liu H et al (2018) Impact of the gut microbiota on intestinal immunity medi- ated by tryptophan metabolism. Front Cell Infect Microbiol 8:13. https://doi.org/10.3389/ fcimb.2018.00013
Kazemi A, Noorbala AA, Azam K et al (2019) Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial. Clin Nutr 38:522-528. https://doi.org/10.1016/j.clnu.2018.04.010
Yano JM, Yu K, Donaldson GP et al (2015) Indigenous bacteria from the gut microbiota regu- late host serotonin biosynthesis. Cell 161:264-276. https://doi.org/10.1016/j.cell.2015.02.047
Roshchina VV (2010) Evolutionary considerations of neurotransmitters in microbial, plant, and animal cells. In: Lyte M, Freestone PPE (eds) Microbial Endocrinology. Springer, New York, pp 17-52. https://doi.org/10.1007/978-1-4419-5576-0_2
Waldecker M, Kautenburger T, Daumann H et al (2008) Inhibition of histone-deacetylase ac- tivity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem 19:587-593. https://doi.org/10.1016/j.jnutbio.2007.08.002
Dalile B, Vervliet B, Bergonzelli G et al (2020) Colon-delivered short-chain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlled trial. Neuropsychopharmacology 45:2257-2266. https://doi.org/10.1038/s41386-020-0732-x
Han A, Sung YB, Chung SY, Kwon MS (2014) Possible additional antidepressant-like mecha- nism of sodium butyrate: targeting the hippocampus. Neuropharmacology 81:292-302. https:// doi.org/10.1016/j.neuropharm.2014.02.017
